Association of immune checkpoint inhibitors therapy with arterial thromboembolic events in cancer patients: A retrospective cohort study

Abstract Background Immune checkpoint inhibitors (ICIs) have emerged as a standard treatment for various malignancies. However, research indicates blocking the immune checkpoint pathway may exacerbate atherosclerotic lesions. Objectives We aimed to investigate whether ICI therapy increases the risk...

Full description

Bibliographic Details
Main Authors: Jie Zhu, Yue Chen, Yuanlong Zhang, Wei Wang, Yujue Wang, Zhuo Lu, Yulin Zhang, Haike Lei, Dairong Li, Bo Long, Haixia Liu
Format: Article
Language:English
Published: Wiley 2023-09-01
Series:Cancer Medicine
Subjects:
Online Access:https://doi.org/10.1002/cam4.6455